Lataa...
The Cost-Effectiveness of Rotavirus Vaccination in Malawi
Background. Rotarix (GlaxoSmithKline), a newly licensed rotavirus vaccine requiring 2 doses, may have the potential to save hundreds of thousands of lives in Africa. Nations such as Malawi, where Rotarix is currently under phase III investigation, may nevertheless face difficult economic choices in...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The University of Chicago Press
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3962285/ https://ncbi.nlm.nih.gov/pubmed/20684689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/653578 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|